What is the most recent FDA action against Zimmer GmbH?

The most recent FDA event Argus HQ has on file for Zimmer GmbH is dated 2024-09-18, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Zimmer GmbH automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Zimmer GmbH is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Zimmer GmbH?

2 total: 0 warning letters, 2 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Zimmer GmbH?

September 18, 2024. Argus HQ ingests new FDA enforcement records daily.

FDA Actions Against Zimmer GmbH

At a glance: Argus HQ has recorded 2 FDA events for Zimmer GmbH: 0 warning letters, 2 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2024-09-18 to 2024-09-18. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

FDA action counts

Total FDA actions	2
Warning letters	0
Recalls	2
Approval records	0
Form 483 inspection citations	0
Most recent action	September 18, 2024

Enforcement history

On 2024-09-18, Argus HQ recorded an FDA recall for Zimmer GmbH, rated "high" severity in Argus HQ's classification: Zimmer GmbH — Class II recall: Biolox Option Taper Sleeve, Type 1 Taper, -6mm Neck - Indicated for use in total…. On 2024-09-18, Argus HQ recorded an FDA recall for Zimmer GmbH, rated "high" severity in Argus HQ's classification: Zimmer GmbH — Class II recall: Biolox Option Taper Sleeve, Type 1 Taper, Standard Neck - Indicated for use in t…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Zimmer GmbH has 2 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

What is the most recent FDA action against Zimmer GmbH?: The most recent FDA event Argus HQ has on file for Zimmer GmbH is dated 2024-09-18, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for Zimmer GmbH automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Zimmer GmbH is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Zimmer GmbH?: 2 total: 0 warning letters, 2 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Zimmer GmbH?: September 18, 2024. Argus HQ ingests new FDA enforcement records daily.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Sep 18, 2024

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2024). FDA Actions Against Zimmer GmbH. Digital Empire LLC. Retrieved from https://argushq.ai/company/zimmer-gmbh

MLA

"FDA Actions Against Zimmer GmbH." Argus HQ Research, Digital Empire LLC, 2024, argushq.ai/company/zimmer-gmbh.

Chicago

Argus HQ Research. "FDA Actions Against Zimmer GmbH." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/company/zimmer-gmbh.

BibTeX

@misc{argushq_argushq_ai_company_zimmer_gmbh_2024,
  title = {FDA Actions Against Zimmer GmbH},
  author = {{Argus HQ Research}},
  year = {2024},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/zimmer-gmbh},
  note = {Accessed: July 17, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗